PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2004ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)244 citations

Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice

View Full Paper
AVAgostino VirdisMNMário Fritsch NevesFAFarhad Amiri

Key Result

The NAD(P)H oxidase inhibitor apocynin prevented blood pressure elevation, structural alterations, endothelial dysfunction, and collagen deposition in small arteries of Angiotensin II-infused mice.

Key Points

  • To determine whether vascular NAD(P)H oxidase activity mediates structural and functional alterations in resistance arteries during angiotensin II-induced hypertension.
  • Mice were treated for 14 days with subcutaneous angiotensin II alone (400 ng/kg/min), angiotensin II with apocynin (2.5 mg/day in food), apocynin alone, or angiotensin II with hydralazine (50 mg/kg/day).
  • Systolic blood pressure was monitored via tail-cuff, pressurized mesenteric resistance arteries were evaluated for structure and relaxation, and vascular collagen I/III was quantified by confocal immunofluorescence and immunoblotting.
  • Angiotensin II significantly increased systolic blood pressure (P < 0.001) and media/lumen ratio (P < 0.01), both of which were prevented by apocynin co-administration.
  • Apocynin normalized elevated vascular NAD(P)H oxidase activity (P < 0.001), restored impaired acetylcholine-mediated vascular relaxation (P < 0.001), and prevented collagen type I/III accumulation.
  • Hydralazine lowered systolic blood pressure similarly to apocynin but failed to prevent the increase in vascular collagen content.

Structured PICO

Does apocynin prevent vascular alterations and blood pressure elevation in Angiotensin II-infused mice?

P
Population
Mice infused with Angiotensin II (400 ng/kg per min, subcutaneously)
I
Intervention
Apocynin (NAD(P)H oxidase inhibitor, 2.5 mg/day, in the food) or hydralazine (50 mg/kg per day) for 14 days
C
Comparator
Angiotensin II alone or apocynin alone
O
Outcome
Systolic blood pressure (SBP), function and structure of small mesenteric arteries, vascular collagen type I/III content, and vascular NAD(P)H oxidase activitysurrogate

In a mouse model of Angiotensin II-dependent hypertension, NAD(P)H oxidase inhibition with apocynin prevented blood pressure elevation, endothelial dysfunction, and vascular structural changes including collagen deposition.

Main Result

p-value: p=<0.001

Abstract

OBJECTIVES: Angiotensin (Ang) II stimulates vascular reactive oxygen species generation via NAD(P)H oxidase activation. We investigated whether vascular NAD(P)H oxidase influences structure and function of resistance arteries from Ang II-infused mice. METHODS: Mice received Ang II alone (400 ng/kg per min, subcutaneously), Ang II + apocynin (NAD(P)H oxidase inhibitor, 2.5 mg/day, in the food), apocynin alone or Ang II + hydralazine (50 mg/kg per day) for 14 days. Systolic blood pressure (SBP) was measured by tail-cuff methodology and function and structure of small mesenteric arteries were studied in pressurized vessels. Vascular collagen type I/III content was evaluated by confocal immunofluorescence microscopy and by immunoblotting. RESULTS: The rise in SBP induced by Ang II (P < 0.001) was prevented by apocynin and hydralazine. Media/lumen ratio increase in Ang II-infused mice (P < 0.01) was prevented by apocynin. Acetylcholine-mediated relaxation, which was impaired in Ang II-infused mice (P < 0.001), was improved by apocynin. Confocal microscopy and immunoblotting demonstrated increased collagen type I/III content in mesenteric arteries from Ang II-infused mice. Apocynin, but not hydralazine, prevented the increase in collagen abundance in Ang II-infused mice. The increase in vascular NAD(P)H oxidase activity by Ang II (P < 0.001) was prevented by apocynin. CONCLUSIONS: The NAD(P)H oxidase inhibitor apocynin reduced blood pressure elevation and prevented structural alterations, endothelial dysfunction, and collagen deposition in the media of small arteries in Ang II-infused mice. Although hydralazine also decreased blood pressure, it had no effects on vascular collagen content. Our findings suggest that NAD(P)H oxidase activity plays an important role in vascular functional and structural changes and in the composition of the vascular wall in Ang II-dependent hypertension.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Virdis et al. (2004) studied Angiotensin II-dependent hypertension. Apocynin vs. Angiotensin II alone or Angiotensin II + hydralazine was evaluated on Systolic blood pressure and vascular structural/functional alterations (p=<0.001). The NAD(P)H oxidase inhibitor apocynin prevented blood pressure elevation, structural alterations, endothelial dysfunction, and collagen deposition in small arteries of Angiotensin II-infused mice.

synapsesocial.com/papers/6a0b242c48609dcc0aace142https://doi.org/10.1097/00004872-200403000-00016
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Arterial Vasodilation and Vascular Connective Tissue Changes in Spontaneously Hypertensive Rats1998 · 34 citations
  2. 2Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress2002 · 399 citations
  3. 3Angiotensin II Induces p67 phox mRNA Expression and NADPH Oxidase Superoxide Generation in Rabbit Aortic Adventitial Fibroblasts1998 · 230 citations
  4. 4Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II1997 · 457 citations
  5. 5Novel gp91 phox Homologues in Vascular Smooth Muscle Cells2001 · 840 citations